Skip to main content

Brookmont Capital Management

Position in GILD — Gilead Sciences, Inc.

CIK 1512978 Dallas, TX

Position in GILD

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$4,780,326
-$473,504 QoQ
Shares Held
37,837
+0.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.68%
of 13F equity value
Holder Rank
#590
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Brookmont Capital Management holds $13,411,938 across 3 Drug Manufacturers - General names. GILD ranks #2 (35.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 GILD
Gilead Sciences, Inc.
This page
37,837 $4,780,326

All Filings in GILD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,780,326 37,837
2026-03-31 $5,253,830 37,697
2025-12-31 $4,491,424 36,593
2025-09-30 $4,067,595 36,645
2025-06-30 $4,163,279 37,551
2025-03-31 $4,312,916 38,491
2024-12-31 $4,718,536 51,083
2024-09-30 $3,668,922 43,761
2024-06-30 $3,100,897 45,196
2024-03-31 $3,419,603 46,684
2023-12-31 $3,700,455 45,679
2023-09-30 $3,484,035 46,491
2023-06-30 $3,608,186 46,817
2023-03-31 $3,882,332 46,792
2022-12-31 $3,998,893 46,580
2022-09-30 $1,810,107 29,342
2022-06-30 $1,668,622 26,996
2022-03-31 $1,584,045 26,645
2021-12-31 $1,893,233 26,074
2021-09-30 $1,898,383 27,178
2021-06-30 $1,836,083 26,664
2021-03-31 $1,722,130 26,646
2020-12-31 $1,541,909 26,466
2020-09-30 $1,777,913 28,136
2020-06-30 $2,124,928 27,618
2020-03-31 $2,899,342 38,782